查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1595463

聚合酵素链锁反应市场：按产品、技术、应用和最终用户划分 - 2025-2030 年全球预测

Polymerase Chain Reaction Market by Product (Consumables & Reagents, Instruments, Software & Services), Technology (Digital PCR, Real-time PCR, Traditional PCR), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

聚合酵素链锁反应市场2023年估值为90.8亿美元，预计2024年将达到102亿美元，复合年增长率为12.57%，预计2030年将达到208.2亿美元。

聚合酵素链锁反应(PCR) 是分子生物学中的一项革命性技术，可扩增 DNA 序列，在基因组学、临床诊断、法医学和生物技术等领域变得至关重要。对 PCR 的需求源于其能够快速准确地检测和定量各种样本中的核酸的能力，这使其在病原体检测、遗传疾病和研究应用中极为重要。 PCR 的应用和最终用途范围广泛，从临床诊断和研究实验室到农业生物技术和环境监测。 PCR 市场的主要成长要素是感染疾病和遗传性疾病的日益普及、数位 PCR 等 PCR 技术的进步以及对个人化医疗的需求不断增加。此外，疫情凸显了强大诊断能力的重要性，进一步推动了 PCR 市场的扩张。由于医疗保健基础设施的成长和研究倡议的增加，新兴市场，特别是亚太地区的新兴市场提供了巨大的商机。然而，市场面临着设备成本高、法规结构严格以及来自次世代定序（NGS）等替代技术的竞争压力等挑战。此外，PCR 技术仍需要创新，特别是在提高灵敏度、速度和通量方面。开发更具成本效益、可携式且易于使用的 PCR 系统是一个有前景的研究和商业创新领域。此外，人工智慧和生物资讯工具的整合以实现更好的资料管理和解释可以提供竞争优势。 PCR 市场的本质是动态的，不断进步并且高度重视研究和开发。公司必须保持敏捷性并投资于最尖端科技和策略伙伴关係，以抓住新机会。为了克服当前的限制，专注于持续创新、产品多样化和应用领域的扩展将是不断发展的 PCR 市场持续成长的关键。

主要市场统计
基准年[2023] 90.8亿美元
预测年份 [2024] 102亿美元
预测年份 [2030] 208.2亿美元
复合年增长率（%） 12.57%

市场动态：快速发展的聚合酵素链锁反应市场的关键市场洞察

供需的动态交互作用正在改变聚合酵素链锁反应市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 感染疾病、癌症和遗传疾病的盛行率上升
    • 生命科学和生物製药研发活动增加
    • 食品和饮料行业需求不断增长
  • 市场限制因素
    • 与聚合物链反应相关的高成本
  • 市场机会
    • 高灵敏度和优化的聚合物链反应装置简介
    • 分子生物学、生命科学和生物技术的技术进步
  • 市场挑战
    • 聚合物链反应系统的技术限制

波特的五力：驾驭聚合酵素链锁反应市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解聚合酵素链锁反应市场的外部影响

外部宏观环境因素在塑造聚合酵素链锁反应市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解聚合酵素链锁反应市场的竞争格局

聚合酵素链锁反应市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵聚合酵素链锁反应市场供应商绩效评估

FPNV 定位矩阵是评估聚合酵素链锁反应市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了聚合酵素链锁反应市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，聚合酵素链锁反应市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 感染疾病、癌症和遗传疾病的发生率增加
      • 生命科学和生物製药研发活动增加
      • 食品和饮料行业需求不断增长
    • 抑制因素
      • 与聚合物链反应相关的高成本
    • 机会
      • 高灵敏度和优化的聚合物链反应装置简介
      • 分子生物学、生命科学和生物技术的技术进步
    • 任务
      • 聚合物链反应系统的技术限制
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章聚合酵素链锁反应市场：副产品

  • 耗材及试剂
  • 装置
  • 软体和服务

第七章聚合酵素链锁反应市场：依技术分类

  • 数位PCR
  • 即时PCR
  • 常规PCR

第八章聚合酵素链锁反应市场：依应用

  • 药品
    • 临床
      • 验血
      • 肿瘤检查
      • 病理检查
    • 法医学
    • 调查
  • 非医疗的
    • 农业
    • 食物

第九章聚合酵素链锁反应市场：依最终用户分类

  • 学术研究所
  • 生技公司
  • 合约研究机构/契约製造机构
  • 诊断实验室
  • 医院

第十章美洲聚合酵素链锁反应市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区聚合酵素链锁反应市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲/中东/非洲聚合酵素链锁反应市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • 新一代 qPCR 试剂突破性能极限
    • 总部位于孟买的 Rivera Lab 从 Amicus 和 Kotak Investment Advisors 筹集资金
    • 罗氏推出新的分子诊断系统“Cobas 5800”，以扩大在美国进行 PCR 检测的机会
    • 博世的 Vivalytic 平台提供新型 PCR 快速检测 MRSA
    • Morbio Diagnostics 成为独角兽并获淡马锡控股 8500 万美元融资
    • Genomadix 宣布与 Mayo Clinic 签订专有授权合约
    • 金斯瑞推出猴痘 PCR 检测
    • Zymo Research 投资 Star Array 开发 PCR 平台
    • 北约克生命科学公司获得 250 万美元的国家资金，用于帮助生产 PCR 检测化学品
    • 罗氏已在接受 CE 标誌的国家将其 COVID-19 PCR 检测产品组合扩展到新的 cobas 5800 系统。
  • 战略分析和建议

公司名单

  • 10x Genomics, Inc.
  • 3M Company
  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Azure Biosystems Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux, SA
  • Danaher Corporation
  • Eppendorf SE
  • F. Hoffmann-La Roche Ltd.
  • Fluidigm Corporation
  • GeneCopoeia, Inc.
  • Illumina, Inc.
  • JN Medsys Pte. Ltd.
  • Kawasaki Heavy Industries, Ltd.
  • KYORIN Pharmaceutical Co., Ltd.
  • LabTurbo Biotech Corporation
  • LGC Limited
  • MBS Molecular Biology Systems
  • Merck KGaA
  • Microsynth AG
  • Molbio Diagnostics Pvt. Ltd.
  • Ningbo Scientz Biotechnology Co., Ltd.
  • Promega Corporation
  • Shimadzu Corporation
  • Siemens AG
  • Standard BioTools
  • Stilla Technologies
  • Stilla Technologies Inc.
  • SV SCIENTIFIC PRIVATE LIMITED
  • Sysmex AG
  • Takara Bio Inc.
  • Thermo Fisher Scientific, Inc.
  • VWR International, LLC by Avantor, Inc.
Product Code: MRR-205091A8890D

The Polymerase Chain Reaction Market was valued at USD 9.08 billion in 2023, expected to reach USD 10.20 billion in 2024, and is projected to grow at a CAGR of 12.57%, to USD 20.82 billion by 2030.

Polymerase Chain Reaction (PCR) is a revolutionary technique in molecular biology that allows for the amplification of DNA sequences, making it indispensable in fields such as genomics, clinical diagnostics, forensic science, and biotechnology. The necessity of PCR arises from its ability to quickly and accurately detect and quantify nucleic acids in various samples, which is crucial in pathogen detection, genetic diseases, and research applications. The application and end-use scope of PCR are vast, ranging from clinical diagnostics and research institutions to agricultural biotechnology and environmental monitoring. Key growth factors in the PCR market include the increasing prevalence of infectious diseases and genetic disorders, advancements in PCR technologies such as digital PCR, and a rising demand for personalized medicine. Moreover, the pandemic has underscored the importance of robust diagnostic capabilities, further propelling PCR's market expansion. Emerging markets, especially in Asia-Pacific, represent significant opportunities due to their growing healthcare infrastructure and increasing research initiatives. However, the market faces challenges such as high equipment costs, stringent regulatory frameworks, and competitive pressure from alternative technologies like next-generation sequencing (NGS). Furthermore, there is an ongoing need for innovation in PCR technology, particularly in enhancing sensitivity, speed, and throughput. Developing more cost-effective, portable, and user-friendly PCR systems represents a promising area of research and business innovation. Additionally, integrating AI and bioinformatics tools for better data management and interpretation could provide competitive advantages. The nature of the PCR market is dynamic, with continuous advancements and a strong focus on research and development. Companies must remain agile and invest in cutting-edge technologies and strategic partnerships to capitalize on new opportunities. To overcome current limitations, focusing on continuous innovation, product diversification, and expanding application areas will be key to sustaining growth in the evolving PCR market landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 9.08 billion
Estimated Year [2024] USD 10.20 billion
Forecast Year [2030] USD 20.82 billion
CAGR (%) 12.57%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Polymerase Chain Reaction Market

The Polymerase Chain Reaction Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the prevalence of infectious diseases, cancer, and genetic disease
    • Increasing life science and biopharmaceutical research and development activities
    • Growing demand in the food & beverage industry
  • Market Restraints
    • High cost associated with a polymer chain reaction
  • Market Opportunities
    • Introduction of high sensitive and optimized polymer chain reaction instruments
    • Technological advancements in molecular biology, life sciences, and biotechnology
  • Market Challenges
    • Technical limitations of polymer chain reaction systems

Porter's Five Forces: A Strategic Tool for Navigating the Polymerase Chain Reaction Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Polymerase Chain Reaction Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Polymerase Chain Reaction Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Polymerase Chain Reaction Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Polymerase Chain Reaction Market

A detailed market share analysis in the Polymerase Chain Reaction Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Polymerase Chain Reaction Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Polymerase Chain Reaction Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Polymerase Chain Reaction Market

A strategic analysis of the Polymerase Chain Reaction Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Polymerase Chain Reaction Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, ACON Laboratories, Inc., Agilent Technologies, Inc., Azure Biosystems Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux, S.A., Danaher Corporation, Eppendorf SE, F. Hoffmann-La Roche Ltd., Fluidigm Corporation, GeneCopoeia, Inc., Illumina, Inc., JN Medsys Pte. Ltd., Kawasaki Heavy Industries, Ltd., KYORIN Pharmaceutical Co., Ltd., LabTurbo Biotech Corporation, LGC Limited, MBS Molecular Biology Systems, Merck KGaA, Microsynth AG, Molbio Diagnostics Pvt. Ltd., Ningbo Scientz Biotechnology Co., Ltd., Promega Corporation, Shimadzu Corporation, Siemens AG, Standard BioTools, Stilla Technologies, Stilla Technologies Inc., SV SCIENTIFIC PRIVATE LIMITED, Sysmex AG, Takara Bio Inc., Thermo Fisher Scientific, Inc., and VWR International, LLC by Avantor, Inc..

Market Segmentation & Coverage

This research report categorizes the Polymerase Chain Reaction Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables & Reagents, Instruments, and Software & Services.
  • Based on Technology, market is studied across Digital PCR, Real-time PCR, and Traditional PCR.
  • Based on Application, market is studied across Medical and Non-Medical. The Medical is further studied across Clinical, Forensics, and Research. The Clinical is further studied across Blood screening, Oncology testing, and Pathology testing. The Non-Medical is further studied across Agriculture and Food.
  • Based on End-User, market is studied across Academic Research Institutes, Biotechnology Companies, Contract Research Organization/ Contract Manufacturing Organization, Diagnostic Laboratories, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of infectious diseases, cancer, and genetic disease
      • 5.1.1.2. Increasing life science and biopharmaceutical research and development activities
      • 5.1.1.3. Growing demand in the food & beverage industry
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with a polymer chain reaction
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of high sensitive and optimized polymer chain reaction instruments
      • 5.1.3.2. Technological advancements in molecular biology, life sciences, and biotechnology
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations of polymer chain reaction systems
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Polymerase Chain Reaction Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables & Reagents
  • 6.3. Instruments
  • 6.4. Software & Services

7. Polymerase Chain Reaction Market, by Technology

  • 7.1. Introduction
  • 7.2. Digital PCR
  • 7.3. Real-time PCR
  • 7.4. Traditional PCR

8. Polymerase Chain Reaction Market, by Application

  • 8.1. Introduction
  • 8.2. Medical
    • 8.2.1. Clinical
      • 8.2.1.1. Blood screening
      • 8.2.1.2. Oncology testing
      • 8.2.1.3. Pathology testing
    • 8.2.2. Forensics
    • 8.2.3. Research
  • 8.3. Non-Medical
    • 8.3.1. Agriculture
    • 8.3.2. Food

9. Polymerase Chain Reaction Market, by End-User

  • 9.1. Introduction
  • 9.2. Academic Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Contract Research Organization/ Contract Manufacturing Organization
  • 9.5. Diagnostic Laboratories
  • 9.6. Hospitals

10. Americas Polymerase Chain Reaction Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Polymerase Chain Reaction Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Polymerase Chain Reaction Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Next Generation of qPCR Reagents push the boundaries of performance
    • 13.3.2. Mumbai-based Rivaara Labs raises funding from Amicus, Kotak investment advisors
    • 13.3.3. Roche introduces the cobas 5800, a new molecular diagnostic system to expand access to PCR testing in the U.S.
    • 13.3.4. Bosch's Vivalytic platform offering new PCR rapid test for MRSA
    • 13.3.5. Molbio Diagnostics raises $85 mn from Temasek at unicorn valuation
    • 13.3.6. Genomadix Inc. announces know-how license agreement with Mayo Clinic
    • 13.3.7. GenScript launches monkeypox PCR test
    • 13.3.8. Zymo Research to invest in Star Array for PCR platform development
    • 13.3.9. North York life sciences company gets $2.5M from provincial fund to help produce PCR test chemicals
    • 13.3.10. Roche expands the COVID-19 PCR test portfolio to the new cobas 5800 System in countries accepting the CE Mark
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 10x Genomics, Inc.
  • 2. 3M Company
  • 3. Abbott Laboratories
  • 4. ACON Laboratories, Inc.
  • 5. Agilent Technologies, Inc.
  • 6. Azure Biosystems Inc.
  • 7. Becton, Dickinson and Company
  • 8. Bio-Rad Laboratories, Inc.
  • 9. bioMerieux, S.A.
  • 10. Danaher Corporation
  • 11. Eppendorf SE
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Fluidigm Corporation
  • 14. GeneCopoeia, Inc.
  • 15. Illumina, Inc.
  • 16. JN Medsys Pte. Ltd.
  • 17. Kawasaki Heavy Industries, Ltd.
  • 18. KYORIN Pharmaceutical Co., Ltd.
  • 19. LabTurbo Biotech Corporation
  • 20. LGC Limited
  • 21. MBS Molecular Biology Systems
  • 22. Merck KGaA
  • 23. Microsynth AG
  • 24. Molbio Diagnostics Pvt. Ltd.
  • 25. Ningbo Scientz Biotechnology Co., Ltd.
  • 26. Promega Corporation
  • 27. Shimadzu Corporation
  • 28. Siemens AG
  • 29. Standard BioTools
  • 30. Stilla Technologies
  • 31. Stilla Technologies Inc.
  • 32. SV SCIENTIFIC PRIVATE LIMITED
  • 33. Sysmex AG
  • 34. Takara Bio Inc.
  • 35. Thermo Fisher Scientific, Inc.
  • 36. VWR International, LLC by Avantor, Inc.

LIST OF FIGURES

  • FIGURE 1. POLYMERASE CHAIN REACTION MARKET RESEARCH PROCESS
  • FIGURE 2. POLYMERASE CHAIN REACTION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. POLYMERASE CHAIN REACTION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. POLYMERASE CHAIN REACTION MARKET DYNAMICS
  • TABLE 7. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CONSUMABLES & REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY DIGITAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY REAL-TIME PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY TRADITIONAL PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY BLOOD SCREENING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY ONCOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY PATHOLOGY TESTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY FORENSICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY AGRICULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY FOOD, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION/ CONTRACT MANUFACTURING ORGANIZATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL POLYMERASE CHAIN REACTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 41. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. AMERICAS POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 47. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 48. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 49. ARGENTINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 52. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 53. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 54. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 55. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 56. BRAZIL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 61. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 62. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 63. CANADA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 68. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 69. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 70. MEXICO POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 75. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 76. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 77. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. UNITED STATES POLYMERASE CHAIN REACTION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 85. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. ASIA-PACIFIC POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 91. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 92. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 93. AUSTRALIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 96. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 98. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 99. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 100. CHINA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 105. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 106. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 107. INDIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 110. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 112. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 113. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 114. INDONESIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 117. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 119. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 120. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 121. JAPAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 124. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 126. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 127. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 128. MALAYSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 131. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 133. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 134. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 135. PHILIPPINES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 138. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 140. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 141. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 142. SINGAPORE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 145. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 146. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 147. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 148. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 149. SOUTH KOREA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 154. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 155. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 156. TAIWAN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 157. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 158. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 161. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 162. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 163. THAILAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 165. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 168. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 169. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 170. VIETNAM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 173. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 179. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 183. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 184. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 185. DENMARK POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 188. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 190. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 191. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 192. EGYPT POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 193. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 196. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 197. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 198. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 199. FINLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 202. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 204. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 205. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 206. FRANCE POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 207. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 208. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 211. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 212. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 213. GERMANY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 215. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 218. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 219. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 220. ISRAEL POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 225. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 226. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 227. ITALY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 228. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 230. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 231. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 232. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 233. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 234. NETHERLANDS POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 239. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 240. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 241. NIGERIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 242. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 243. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 244. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 245. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 246. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 247. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 248. NORWAY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 249. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 250. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 252. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 253. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 254. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 255. POLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 256. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 257. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 258. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 259. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 260. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 261. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 262. QATAR POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 263. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 264. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 266. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 267. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 268. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 269. RUSSIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 270. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 271. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 272. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 273. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 274. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 275. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 276. SAUDI ARABIA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 281. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 282. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 283. SOUTH AFRICA POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 284. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 285. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 286. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 287. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 288. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 289. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 290. SPAIN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 291. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 292. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 294. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 295. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 296. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 297. SWEDEN POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 298. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 299. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 300. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 301. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 302. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 303. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 304. SWITZERLAND POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 305. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 306. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 308. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 309. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 310. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 311. TURKEY POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 312. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 313. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 314. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 315. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 316. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 317. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 318. UNITED ARAB EMIRATES POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 319. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 320. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 322. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 323. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY CLINICAL, 2018-2030 (USD MILLION)
  • TABLE 324. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY NON-MEDICAL, 2018-2030 (USD MILLION)
  • TABLE 325. UNITED KINGDOM POLYMERASE CHAIN REACTION MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 326. POLYMERASE CHAIN REACTION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 327. POLYMERASE CHAIN REACTION MARKET, FPNV POSITIONING MATRIX, 2023